Stroke with Forehead Paralysis: Critical Diagnostic and Management Approach
Key Distinction: This Indicates Central (Upper Motor Neuron) Facial Palsy
Forehead paralysis in a stroke patient signifies involvement of the upper face, which is the hallmark of a central (cortical or subcortical) lesion rather than a peripheral facial nerve problem—this demands immediate comprehensive stroke evaluation and aggressive management. 1
The presence of forehead involvement (inability to wrinkle forehead, raise eyebrows, or close eyes completely) indicates a lower motor neuron pattern, which paradoxically suggests either:
- A pontine/brainstem stroke affecting the facial nucleus or nerve fascicle 2, 3
- Flow-limiting middle cerebral artery (MCA) disease 4
Critical Neurological Findings to Assess Immediately
Perform Standardized NIHSS Examination
Use the National Institutes of Health Stroke Scale to systematically evaluate: 1
Cranial Nerve Assessment:
- Gaze abnormalities (0=normal, 1=partial gaze palsy, 2=forced deviation) 1
- Visual field defects (hemianopia, quadrantanopia, extinction) 1
- Complete facial palsy grading (0=normal, 1=minor asymmetry, 2=partial lower face, 3=complete upper and lower face paralysis) 1
Motor Function:
- Arm drift/weakness bilaterally (test at 90° sitting or 45° supine for 10 seconds) 1
- Leg drift/weakness bilaterally (test at 30° for 5 seconds) 1
- Grade: 0=no drift, 1=drift, 2=some antigravity, 3=no antigravity, 4=no movement 1
Coordination and Sensation:
- Limb ataxia (finger-to-nose, heel-to-shin) 1
- Sensory loss (unilateral vs bilateral, mild vs severe) 1
Language and Cognition:
- Aphasia (expressive, receptive, or global) 1
- Dysarthria (slurred speech) 1
- Neglect/extinction to double simultaneous stimulation 1
- Level of consciousness (alert, drowsy, obtunded, coma) 1
Specific Red Flags for Pontine/Brainstem Involvement
When facial palsy includes forehead involvement, actively search for: 2, 3
- Conjugate gaze palsy (inability to look toward the side of lesion) 3
- Gaze-evoked nystagmus 3
- Vertigo or severe dizziness 3
- Cerebellar signs: truncal ataxia, broad-based gait, dysmetria 3
- Contralateral hemiparesis (if ventral pons involved) 2
- Altered consciousness disproportionate to imaging 5
Vascular Territory Localization
If isolated facial palsy with forehead involvement: 4
- 78% have flow-limiting mid-to-distal M1 or proximal M2 MCA disease 4
- Only 22% have traditional lacunar lesions (corona radiata or pons) 4
- Look for prominent early anterior temporal artery on imaging 4
Immediate Management Algorithm
Acute Stabilization (First 30 Minutes)
Airway and Breathing: 1
- Assess for airway compromise from decreased consciousness or brainstem dysfunction 1
- Monitor oxygen saturation continuously (target >94%) 1
- Position head of bed 20-30° if no hypoxia to optimize cerebral perfusion 1
Vital Signs: 1
- Document blood pressure (severe elevation >220 mmHg suggests hemorrhage or hypertensive encephalopathy) 1
- Check for irregular pulse (atrial fibrillation) 1
- Measure temperature every 4 hours for first 48 hours 5
Swallowing Precautions: 5
- Keep patient NPO until validated swallowing screen completed 5
- High aspiration risk with brainstem involvement 1
Diagnostic Workup
Immediate Imaging (within 25 minutes of arrival): 1
- Non-contrast CT head to exclude hemorrhage 1
- If CT negative but high suspicion: MRI with diffusion-weighted imaging (more sensitive for pontine infarcts) 2, 3
- CT angiography or MR angiography of head and neck to identify vessel occlusion/stenosis 1, 4
- Glucose, electrolytes, complete blood count 5
- PT/INR, aPTT (especially if on anticoagulants) 1, 5
- Troponin and ECG (cardiac source) 1
Thrombolytic Eligibility Assessment
Time-Critical Decision (within 60 minutes): 1
- Establish exact time last known normal (not time found with symptoms) 1
- If within 3-4.5 hour window and no contraindications, consider IV tPA 1
- NIHSS score helps predict hemorrhage risk and outcome 1
Contraindications to assess: 1
- Active bleeding, recent surgery/trauma 1
- Current anticoagulation (INR >1.7) 1
- Severe hypertension (>185/110 mmHg) 1
Management of Acute Complications
Seizure Management (if occurs)
Do NOT use prophylactic anticonvulsants 5
- Prophylaxis impairs neural recovery and cognitive function 5
- No benefit in preventing post-stroke seizures 5
If seizure occurs: 5
- First-line: Lorazepam 4 mg IV at 2 mg/min 5
- Second-line: Levetiracetam 30 mg/kg IV over 5 minutes (not maintenance doses of 500-1000 mg) 5
- Avoid phenytoin due to worse cognitive outcomes 5
Monitoring: 5
- Assess for seizure activity at each vital sign check 5
- Consider continuous EEG for 24-48 hours if consciousness disproportionately reduced 5
Cerebral Edema (peaks at 3-5 days)
Risk factors: 1
Management: 1
- Mild fluid restriction, avoid hypoosmolar fluids (5% dextrose) 1
- Treat hypoxia, hypercarbia, hyperthermia 1
- Elevate head of bed 20-30° 1
- Avoid antihypertensives that cause cerebral vasodilation 1
Infection Prevention
Pneumonia (leading cause of post-stroke death): 1
- Early mobilization when safe 1
- Aspiration precautions until swallow screen passed 1
- Prompt antibiotic therapy if fever develops 1
Deep Vein Thrombosis: 1
- Subcutaneous anticoagulants or intermittent pneumatic compression 1
- Aspirin if anticoagulants contraindicated 1